(Q36637677)

15 August 2017

1 reference

title

Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression (English)

1 reference

15 August 2017

Chittaranjan Andrade

1

1 reference

15 August 2017

Savita G Bhakta

series ordinal

2

1 reference

15 August 2017

Nagendra M Singh

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

World Journal of Biological Psychiatry

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

251-260

1 reference

Suicide attempts in clinical trials with paroxetine randomised against placebo

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Review of the efficacy and safety of antidepressants in youth depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Cognitive therapy vs medications in the treatment of moderate to severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Antidepressants and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Efficacy and safety of antidepressants for children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Combined pharmacotherapy and psychological treatment for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

The treatment of adolescent depression in the era of the black box warning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Antidepressant medications in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970600702690

10.1080/15622970600702690

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference